EUVIMED · CrossrefJournal
European Journal of Medicinal Chemistry Reports
ISSN 2772-4174 · Elsevier BV
Latest articles
Therapeutic evaluation of thiadiazole–piperidinone hybrids as selective anticancer agents for advanced melanoma: Role of PI3K/AKT/mTOR inhibition and induction of cell cycle arrest, apoptosis, and autophagy
Design, synthesis, and biological evaluation of novel oxindole-based derivatives as potent and selective antileukemic agents.
Chemical modification of indirubin reveals a mitochondrial vulnerability and overcomes multidrug resistance in leukemia cells
Affinity selection-mass spectrometry discovery of small molecule ILT3 (LILRB4) binders and pharmacological characterization in Alzheimer's disease models
Study on the antiviral activity and structure–activity relationship of ethylene glycol phenyl aminodiether-based FOXM1 inhibitors
Synthesis of novel lupeol quaternary ammonium salt derivatives: Quantitative proteomics reveals anti-HCC activity through synergistic mitochondrial apoptosis and glycolysis modulation in HepG2 cells
Rational design, preclinical characterization and stability studies of cpHER2_31, a small cyclic peptide for HER2-targeted anticancer applications
A galectin-8-targeting PROTAC decreases galectin-8 levels in MDA-MB-231 breast cancer cells
TPP-Guided Prodrug Design for Host-Directed Antivirals: Niclosamide as a Medicinal Chemistry Case Study
1,4 -naphthoquinone derivatives with anticancer potential: A comprehensive review
Recent advance in the targeted protein degradation technology for overcoming acute leukemia
Design and biological evaluation of imidazo[2,1-a]phthalazine compounds with antiproliferative properties in triple-negative breast cancer cells
Tyrosinase inhibition by hemiindigoid-based compounds with a copper-interacting hydroxamic acid head
Expanding the role of thiophilic metallodrugs in antiparasitic chemotherapy: multi-target approaches against protozoan parasites
ID Card of Mcl-1 PROTAC degrader: From in silico design to biological validation in chemoresistant ovarian cancer
Quinolone inhibitors targeting Vibrio cholerae sodium-dependent NADH: Ubiquinone oxidoreductase (NQR)
Discovery of a highly selective JAK2 inhibitor with a furopyrimidine scaffold
A novel anti-breast cancer stemness agent optimized from marine-derived bisindole Calcicamide A targeting the IL-6/JAK2/STAT3 signaling pathway
Metabolomics analysis of the potential treatment of Fan Bei San Jie Capsule in non-small cell lung cancer
2-Morpholino-substituted imidazothiadiazole TAK1 inhibitors for reduction of proinflammatory cytokines
Peony seed meal extract suppresses hepatocellular carcinoma growth and enhances chemotherapy efficacy
Integrative experimental and network pharmacology analysis reveals Madhunashini as a PAI-1–targeting therapeutic candidate for triple-negative breast cancer associated with diabetes
Alloxanthin, an autophagy inducer, exhibits potent anti-tumor effects by targeting AKR1C3
Retraction notice to “Exploring the antimicrobial potential of novel 2-oxo-2-H-chromene conjugates with guanine, thiazole, and imidazole: Synthesis, characterization, and biological evaluation” [Europ. J. Med. Chem. Rep. 14 (2024) 100179]
Investigation on the antibacterial activity and molecular mechanism of rifamycin derivatives against methicillin-resistant Staphylococcus aureus
Synthesis and first evaluation of new favipiravir analogs based on cyclic amidrazones scaffolds
Synthesis and biological evaluation of C5-(1-substituted-1,2,3-triazol-4-yl)-uridines and their phosphoramidate prodrugs
Small molecule agonists of TREM2 reprogram microglia and protect synapses in human Alzheimer's models
Design, synthesis, in vitro, and in silico assays of new 4-phenylpiperazine-coumarin-triazole-acetamide hybrids as potent tyrosinase inhibitors
Exploring sulfonamide carboxamides as promising leads for antimalarial drug development
EUVIMED